immune checkpoint therapy

The treatments, often referred to as “immune checkpoint therapy”, have “fundamentally changed the outcome for certain groups of patients with advanced cancer”, it added.

Immune checkpoint therapy has revolutionised cancer treatment, said the prize-giving Swedish Academy.

Sharma, P. & Allison, J. P. The future of immune checkpoint therapy.

A promising type of immunotherapy, called immune checkpoint therapy, blocks the “off” signal so your body has more time to mount its own defense.

In December 2014, the PD-1 inhibitor nivolumab became the latest immune checkpoint therapy to gain FDA approval, specifically for the treatment of metastatic lung cancer3.